Infant Bacterial Therapeutics AB (IFTBF)
6.85
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
Infant Bacterial Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2017 | 0.00% |
| Date | Value |
|---|---|
| March 31, 2017 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Orexo AB | -137.1% |
| Swedencare AB | 7.63% |
| Camurus AB | 92.70% |
| Moberg Pharma AB | 65.36% |
| AstraZeneca PLC | 76.09% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -60.53% |
| Return on Assets | -41.03% |
| Return on Invested Capital | -60.53% |
| Return on Net Operating Assets | -757.7% |